Company news
Zhaoke Ophthalmology Ltd. news in 2026
Zhaoke Ophthalmology Ltd.'s news releases, calls and decks from 2026, newest first.
Inside information - the company's self-developed innovative drug Cyclosporine Ophthalmic Gel receives marketing approval from the national medical products administration
November 13, 2026
Next Day Disclosure Return
November 8, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 3, 2026
Next Day Disclosure Return
October 27, 2026
Voluntary announcement - Zhaoke Ophthalmology's manufacturing facility obtains gmp certification from the therapeutic goods administration of australia ("tga")
October 26, 2026
Next Day Disclosure Return
October 26, 2026
Next Day Disclosure Return
October 23, 2026
Next Day Disclosure Return
October 22, 2026
Next Day Disclosure Return
October 21, 2026
Next Day Disclosure Return
October 20, 2026
(Revised) Next Day Disclosure Return (Amendment for the return on 16 October November 2026)
October 20, 2026
(Revised) Next Day Disclosure Return (Amendment for the return on 15 October November 2026)
October 20, 2026
Next Day Disclosure Return
October 16, 2026
Next Day Disclosure Return
October 15, 2026
Next Day Disclosure Return
October 15, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 1, 2026
2026 Interim Report
September 30, 2026
Notification letter to registered shareholders and reply form
September 30, 2026
Notification letter to non-registered shareholders and reply form
September 30, 2026